Your Reliable Source for APIs and Pharma Intermediates in India
At Punagri Organics and Lifesciences, we understand that today’s pharmaceutical companies truly need quality, trust, and consistency. We are Based in Vapi, Gujarat. We have earned our place as a leading API manufacturer in India. Our quality levels reflect international industry standards and are comparable with pharmaceutical intermediates manufacturers in China.
We have modern systems and a science-focused team that supports companies worldwide. We provide high-purity APIs and special intermediates made with green chemistry.
We are a contract development and manufacturing company delivering quality that meets global expectations.
Punagri delivers everything with accuracy and care, whether you need bulk production or key ingredients for complex formulas.
Search Box (All Fields Optional)
| SL | Pharma Intermediates | CAS number | Structures | API | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
1
|
5-Ethyl-2-methylpyridine
|
104-90-5
|
![]() |
Etoricoxib |
||||||||||||||||
|
|
2
|
4-Amino-2-methylbenzoic acid
|
2486-75-1
|
![]() |
Tolvaptan |
||||||||||||||||
|
|
3
|
5-Cyanophthalide
|
82104-74-3
|
![]() |
Citalopram, Escitalopram |
||||||||||||||||
|
|
4
|
Cyanodiol Hbr
₹2,000.00 |
103146-26-5
|
![]() |
Citalopram, Escitalopram |
||||||||||||||||
|
|
5
|
Cyanodiol HCl
₹2,000.00 |
717133-25-0
|
![]() |
Citalopram, Escitalopram |
||||||||||||||||
|
|
6
|
Cyanodiol Base
₹2,000.00 |
103146-25-4
|
![]() |
Citalopram, Escitalopram |
||||||||||||||||
|
|
7
|
3-Methoxy-4-methylbenzoic acid
₹2,000.00 |
7151-68-0
|
![]() |
Zafirlukast, Finerenone |
||||||||||||||||
|
|
8
|
4-Cyano-2-methoxybenzaldehyde
₹2,000.00 |
21962-45-8
|
![]() |
Finerenone |
||||||||||||||||
|
|
9
|
5-Nitroindazole
₹2,000.00 |
5401-94-5
|
![]() |
BMS-599626, Belumosudil |
||||||||||||||||
|
|
10
|
3,4-Dihydroxy-5-nitrobenzaldehyde
₹2,000.00 |
116313-85-0
|
![]() |
Entacapone |
||||||||||||||||
|
|
11
|
Ethyl 2-aminothiazole-5-carboxylate
₹2,000.00 |
32955-21-8
|
![]() |
Dasatinib, Ceftibuten |
||||||||||||||||
|
|
12
|
2-Chloro-6-methylaniline
₹2,000.00 |
87-63-8
|
![]() |
Dasatinib, Duvelisib |
||||||||||||||||
|
|
13
|
2-Bromoethanol
₹2,000.00 |
540-51-2
|
![]() |
Umeclidinium Bromide, Citicoline, Quetiapine |
||||||||||||||||
|
|
14
|
2-Amino-5-methylthiazole
|
7305-71-7
|
![]() |
Meloxicam |
||||||||||||||||
|
|
15
|
5-Nitroisophthalic acid
|
618-88-2
|
![]() |
Iohexol, Iopamidol |
||||||||||||||||
|
|
16
|
3-Nitrobenzaldehyde
₹2,000.00 |
99-61-6
|
![]() |
Lercanidipine, Nicardipine, Cilnidipine |
||||||||||||||||
|
|
17
|
Dimethyl anthranilate
₹2,000.00 |
85-91-6
|
![]() |
Dibenzepin |
||||||||||||||||
|
|
18
|
3,5-Diiodosalicylic Acid
₹2,000.00 |
133-91-5
|
![]() |
Rafoxanide |
||||||||||||||||
|
|
19
|
1,4-Dimethoxybenzene
₹2,000.00 |
150-78-7
|
![]() |
Midodrine hydrochloride |
||||||||||||||||
|
|
20
|
4-Methoxyphenol
₹2,000.00 |
150-76-5
|
![]() |
Tiratricol , Levothyroxine, Azelaic Acid |
||||||||||||||||
|
|
21
|
4-Methoxy-2-nitroaniline
₹2,000.00 |
96-96-8
|
![]() |
Omeprazole Sodium, Primaquine Phosphate |
||||||||||||||||
|
|
22
|
5-Aminoindazole
₹2,000.00 |
19335-11-6
|
![]() |
Belumosudil Mesylate |
||||||||||||||||
|
|
23
|
6-Nitroindazole
₹2,000.00 |
7597-18-4
|
![]() |
Axitinib |
||||||||||||||||
|
|
24
|
3-Iodo-6-nitroindazole
₹2,000.00 |
70315-70-7
|
![]() |
Axitinib |
||||||||||||||||
|
|
25
|
2-Methyl-5-nitroaniline
₹2,000.00 |
99-55-8
|
![]() |
Imatinib |
||||||||||||||||
|
|
26
|
4-Ethylphenol
x
₹2,000.00 |
123-07-9
|
![]() |
Ambroxol / Sorafenib |
||||||||||||||||
|
|
27
|
4-(2,3-epoxypropoxy)-carbazole
₹2,000.00 |
51997-51-4
|
![]() |
Carvedilol |
||||||||||||||||
|
|
28
|
2-(2-methoxyphenoxy) ethylamine
₹2,000.00 |
1836-62-0
|
![]() |
Amosulalol, Carvedilol |
||||||||||||||||
|
|
29
|
tert-Butyl carbazate
₹2,000.00 |
870-46-2
|
![]() |
Ibrutinib/ Olaparib / Gliclazide |
||||||||||||||||
|
|
30
|
N-Methyl-3-phenyl-3-hydroxypropylamine
₹2,000.00 |
42142-52-9
|
![]() |
Atomoxetine, Fluoxetine |
||||||||||||||||
|
|
31
|
5-Nitroindole
₹2,000.00 |
6146-52-7
|
![]() |
Zafirlukast |
||||||||||||||||
|
|
32
|
N-Methylformanilide
₹2,000.00 |
93-61-8
|
![]() |
Fluvastatin sodium |
||||||||||||||||
|
|
33
|
5-Aminoisophthalic acid
|
99-31-0
|
![]() |
Iohexol |
||||||||||||||||
|
|
34
|
5-Nitrovanillin
₹2,000.00 |
6635-20-7
|
![]() |
Entacapone |
||||||||||||||||
|
|
35
|
4-Bromo-1-methyl-1H-pyrazole
₹2,000.00 |
15803-02-8
|
![]() |
BIT-225 / Savolitinib |
||||||||||||||||
|
|
36
|
Benzylhydrazine dihydrochloride
₹2,000.00 |
20570-96-1
|
|
Heterocyclic amides as inhibitors of receptor interacting protein kinase 1 (RIPK1) |
||||||||||||||||
|
|
37
|
α-Pinene oxide
₹2,000.00 |
1686-14-2
|
![]() |
Sobrerol |
||||||||||||||||
|
|
38
|
Methyl-3-cyanobenzoate
₹2,000.00 |
13531-48-1
|
![]() |
Ataluren |
||||||||||||||||
|
|
39
|
1-(2-methyl-5-nitrophenyl)-guanidine nitrate
₹2,000.00 |
152460-08-7
|
![]() |
Imatinib |
||||||||||||||||
|
|
40
|
2-Amino-6-thiocyanato -benzothiazole
₹2,000.00 |
7170-77-6
|
![]() |
c-Met kinase inhibitor, SAR-125844 |
||||||||||||||||
|
|
41
|
4-Nitroguaiacol
₹2,000.00 |
3251-56-7
|
![]() |
Gefitnib, SB-568849 |
||||||||||||||||
|
|
42
|
Isopropyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide
₹2,000.00 |
118854-48-1
|
![]() |
Meloxicam |
||||||||||||||||
|
|
43
|
2-Methyl-4-nitroaniline
₹2,000.00 |
99-52-5
|
![]() |
Tolvaptan |
||||||||||||||||
|
|
44
|
2-Chloro-2',6'-dimethylacetanilide
₹2,000.00 |
1131-01-7
|
![]() |
Lidocaine / Ranolazine |
||||||||||||||||
|
|
45
|
2-[(3,5-Dimethylphenoxy)methyl]oxirane
₹2,000.00 |
4287-30-3
|
![]() |
Metaxalone |
||||||||||||||||
|
|
46
|
4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile oxalate
|
717133-32-9
|
![]() |
Escitalopram |
||||||||||||||||
|
|
47
|
1-Amino-3-(3,5-dimethylphenoxy)propan-2-ol
|
66766-07-2
|
![]() |
Metaxalone |
||||||||||||||||
|
|
48
|
2-Chlorobenzimidazole
₹2,000.00 |
4857-06-1
|
![]() |
Emedastine, Lansoprazole, Mizolastine |
||||||||||||||||
|
|
49
|
N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide
|
5294-61-1
|
![]() |
Ranolazine |
||||||||||||||||
|
|
50
|
1-(2-Methoxyphenoxy)-2,3-epoxypropane
₹2,000.00 |
2210-74-4
|
![]() |
Methocarbamol / Ranolazine |
||||||||||||||||
|
|
51
|
3-(3,5-dimethylphenoxy)propane-1,2-diol
₹2,000.00 |
59365-66-1
|
![]() |
Metaxalone |
||||||||||||||||
|
|
52
|
5-Aminoindole
₹2,000.00 |
5192-03-0
|
![]() |
HIV protease inhibitors / Anti-cancer agent |
||||||||||||||||
|
|
53
|
2-Bromo-4-nitroanisole
₹2,000.00 |
5197-28-4
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
54
|
1,3-Indanedione
|
606-23-5
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
55
|
2-chloro-5-methoxyphenol
₹2,000.00 |
18113-04-7
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
56
|
N-tert-Butyl piperazine
₹2,000.00 |
38216-72-7
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
57
|
N-tert-Butyldiethanolamine
|
2160-93-2
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
58
|
4-Fluoro-2-methylaniline
₹2,000.00 |
452-71-1
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
59
|
2-Amino-4-methoxy-phenol
₹2,000.00 |
20734-76-3
|
![]() |
Iguratimod |
||||||||||||||||
|
|
60
|
4-Bromo-1-chloro-2-(4-ethoxy-benzyl)-benzene (CAS 461432-23-5)
₹2,000.00 |
461432-23-5
|
![]() |
Dapagliflozin / Empagliflozin |
||||||||||||||||
|
|
61
|
(S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran
₹2,000.00 |
915095-89-5
|
![]() |
Empagliflozin |
||||||||||||||||
|
|
62
|
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran
₹2,000.00 |
915095-94-2
|
![]() |
Empagliflozin |
||||||||||||||||
|
|
63
|
(Z)-Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate
₹2,000.00 |
27143-07-3
|
![]() |
Apixaban |
||||||||||||||||
|
|
64
|
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
₹2,000.00 |
330786-24-8
|
![]() |
Ibrutinib |
||||||||||||||||
|
|
65
|
N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
₹2,000.00 |
1383385-64-5
|
![]() |
Acalabrutinib |
||||||||||||||||
|
|
66
|
2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene
₹2,000.00 |
898566-17-1
|
![]() |
Canagliflozin |
||||||||||||||||
|
|
67
|
4-(Pyridin-2-yl)aminocarbonylphenylboronic acid
₹2,000.00 |
850568-25-1
|
![]() |
Acalabrutinib |
||||||||||||||||
|
|
68
|
Methyl 3-Amino-5-bromo-2-methylbenzoate
₹2,000.00 |
1000342-11-9
|
![]() |
Tazemetostat |
||||||||||||||||
|
|
69
|
5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
₹2,000.00 |
330792-70-6
|
![]() |
Ibrutinib / Zanubrutinib |
||||||||||||||||
|
|
70
|
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene
₹2,000.00 |
1103738-29-9
|
![]() |
Sotagliflozin/ Dapagliflozin |
||||||||||||||||
|
|
71
|
2-Phenylbutyric acid
₹2,000.00 |
90-27-7
|
![]() |
Butamirate Citrate / Indobufen |
||||||||||||||||
|
|
72
|
Ethyl lauroyl arginate HCl
₹2,000.00 |
60372-77-2
|
![]() |
Cosmetic additive |
||||||||||||||||
|
|
73
|
5,6-Dimethoxy indanone
₹2,000.00 |
2107-69-9
|
![]() |
Donepezil |
||||||||||||||||
|
|
74
|
5-Methylisoxazole-4-carboxylic acid
₹2,000.00 |
42831-50-5
|
![]() |
Leflunomide/ Teriflunomide |
||||||||||||||||
|
|
75
|
4-Phenylbutyric acid
₹2,000.00 |
1821-12-1
|
![]() |
Cosmetic additive |
||||||||||||||||
|
|
76
|
Tropic acid
₹2,000.00 |
552-63-6
|
![]() |
Atropine/ Ipratropium bromide |
||||||||||||||||
|
|
77
|
Homoveratric acid
₹2,000.00 |
93-40-3
|
![]() |
Papaverine/ Ivabradine |
||||||||||||||||
|
|
78
|
4-Hydrazinobenzoic acid
₹2,000.00 |
619-67-0
|
![]() |
Deferasirox |
||||||||||||||||
|
|
79
|
1-Indanone
₹2,000.00 |
83-33-0
|
![]() |
Indinavir/ Rasagiline |
||||||||||||||||
|
|
80
|
6-Chloro-m-anisidine
₹2,000.00 |
2401-24-3
|
![]() |
Pilaralisib |
||||||||||||||||
|
|
81
|
6-Chloro-m-anisidine HCl
₹2,000.00 |
85006-21-9
|
![]() |
Pharma intermediate |
||||||||||||||||
|
|
82
|
3-Nitropyrazole
₹2,000.00 |
26621-44-3
|
![]() |
Dorzagliatin |
||||||||||||||||
|
|
83
|
2-Chloro-5-Nitro Toluene
₹2,000.00 |
13290-74-9
|
![]() |
Ponazuril/ Toltrazuril |
||||||||||||||||
|
|
84
|
2-Cyclohexen-1-one
₹2,000.00 |
930-68-7
|
![]() |
Codeine/ Ketoprofen/ Ondansetron |
||||||||||||||||
|
|
85
|
5-Amino-2-chlorophenol
₹2,000.00 |
6358-06-1
|
![]() |
Fluazuron |
||||||||||||||||
|
|
86
|
4-Chloro-3-nitro anisole
₹2,000.00 |
10298-80-3
|
![]() |
Iguratimod/ Netarsudil/ Elacestrant |
||||||||||||||||
|
|
87
|
4-Bromo-3-nitroanisole
₹2,000.00 |
5344-78-5
|
![]() |
Elacestrant |
||||||||||||||||
|
|
88
|
N-Methyl-3,3-diphenylpropan-1-amine hydrochloride
|
29768-15-8
|
![]() |
Lercanidipine |
||||||||||||||||
|
|
89
|
1-Bromo-2-(bromomethyl)-4,5-dimethoxybenzene
|
53207-00-4
|
![]() |
Ivabradine, Pinaverium |
||||||||||||||||
|
|
90
|
5-Bromo-2,4-dichloropyrimidine
|
36082-50-5
|
![]() |
Ribociclib, Trilaciclib, Palbociclib |
||||||||||||||||
|
|
91
|
1-Bromo-3,5-di-tert-butylbenzene
|
22385-77-9
|
![]() |
Nicotine, Baclofen, Arbaclofen |
||||||||||||||||
|
|
92
|
1-(Oxan-4-yl)-1H-pyrazol-3-amine
|
1339391-39-7
|
![]() |
Dorzagliatin |
API and Intermediate Manufacturing Under One Roof
APIs and Pharmaceutical Intermediates are the backbone of effective medicine. Intermediates are essential compounds used in API synthesis. The API is the core ingredient that gives a drug its therapeutic effect.
At Punagri, we are offering a seamless experience for pharmaceutical companies seeking quality ingredients backed by compliance.
Every step from raw material processing to quality testing and packaging is handled by experienced professionals in a compliant environment, consistent with practices common among fine chemical and pharmaceutical raw material suppliers in China.
Our API Capabilities
We will soon manufacture APIs at our state-of-the-art facility.
Quality-Driven Pharma Intermediates
As one of the biggest pharma intermediate manufacturers, we are among the trusted pharma intermediates suppliers in China and India, supporting pharma companies with well-developed intermediates that fit perfectly into their existing synthesis pathways. Each intermediate we produce plays a key role in helping our clients build stronger, more reliable APIs.
Here is what we offer:
- Uniform quality from batch to batch
- Compliance with all relevant guidelines
- Production options from small-scale to large Volume.
- Customisable processes based on your synthesis stage
- We help reduce production risks and improve final product outcomes with this.
Applications & Uses
Pharmaceutical intermediates are the building blocks that allow companies to transform scientific ideas into effective medicines. At Punagri, our intermediates support a wide range of therapies, from generics to specialty formulations.
Our intermediates are widely used in:
- Developing and scaling API intermediates in multiple therapeutic areas
- Reducing risks in complex formulation processes
- Helping pharma companies improve final product reliability
As one of the trusted pharmaceutical intermediate manufacturers, we provide solutions that align with the needs of global buyers.
Future API Capabilities
At Punagri, our vision goes beyond pharma intermediates. With new facilities under development, we are preparing to manufacture Active Pharmaceutical Ingredients (APIs) that meet the same high standards of compliance, quality, and scalability that define our intermediates.
What this means for our clients:
- Access to both pharmaceutical intermediates and APIs under one roof
- Stronger supply chain integration with fewer external dependencies
- Assurance of quality and compliance across the full production cycle
- Support from a single partner for every stage from intermediate synthesis to API development
As we build on our expertise as trusted API intermediates manufacturers, our goal is to provide a smooth bridge between intermediates and APIs, helping global pharma companies bring safe, effective medicines to market faster
Here is what we offer:
- Uniform quality from batch to batch
- Compliance with all relevant guidelines
- Production options from small-scale to large Volume.
- Customisable processes based on your synthesis stage
- We help reduce production risks and improve final product outcomes with this.
Comprehensive Services for Pharmaceutical Clients
Our relationship with clients goes beyond manufacturing. We provide practical, hands-on support that makes sourcing and planning easier. No matter where you are based or how complex your formulation needs may be.
We offer:
- Tailored ingredient solutions based on your formulation goals
- Regulatory support with complete documentation
- Scalable batch options to suit R&D, pilot, or commercial production
- Reliable quality checks built into every step
- Clear and responsive communication at all stages
You will have a knowledgeable partner by your side every time you order.
Supplying to Global Markets
Today, our intermediates are shipped to leading pharmaceutical hubs across the globe. Many of our clients source globally and value suppliers who uphold standards similar to those seen in the China pharmaceutical industry’s leading manufacturers.
We offer:
- Fast, dependable delivery
- Compliance with global safety standards
- Readiness to scale production on demand
- Honest, transparent operations every step of the way
Whether you are in formulation, generics, or distribution, Punagri is equipped to support your pharmaceutical goals globally.
Research & Development Support
Every innovation in medicine begins with small-scale experimentation. That’s why Punagri offers flexible R&D support for pharmaceutical companies developing new products. Our teams provide intermediates in scalable batches, maintaining consistency as projects advance toward commercialization.
With clear documentation and strong regulatory support, we let research teams focus on innovation while we manage the supply challenges. In line with leading contract development and manufacturing companies, we act as a long-term partner to API development teams
We offer:
- Fast, dependable delivery
- Compliance with global safety standards
- Readiness to scale production on demand
- Honest, transparent operations every step of the way
Whether you are in formulation, generics, or distribution, Punagri is equipped to support your pharmaceutical goals globally.
What Makes Us Different
Choosing the right manufacturing partner can make all the difference. Here is why more pharma brands are choosing Punagri Organics and Lifesciences:
Full-Spectrum Capabilities: We can support you with products ranging from Key Starting Materials (KSMs) to Advanced Intermediates.
Strict Compliance: We are oriented towards achieving GMP and regulatory accreditations from various international bodies.
Purity First: Our processes are geared to deliver high-quality, clean products
Eco-Conscious Chemistry: We prioritise safe, sustainable production practices
Experienced Team: Skilled scientists and process experts at every stage
Trusted Worldwide: Our products reach pharma leaders across global markets
Dependable Delivery: Timelines you can count on, every time
Let’s Work Together
At Punagri Organics and Lifesciences, we do more than just provide ingredients. We help you make better medicines. With strong regulatory systems, modern facilities, and a responsive team, we are committed to delivering bulk intermediate pharma products and APIs that meet your quality expectations and business goals.
Frequently Asked Questions
APIs are the final active ingredients in drugs. Intermediates are chemical steps used to make those APIs. Intermediates are processed further to form the API. Our pharma intermediates are developed with expertise comparable to leading API intermediates manufacturers in the world, including China.
Punagri is in process of getting GMP certified.
Punagri will soon manufacture APIs.
Currently, we are only manufacturing Pharma Intermediates, and soon we will be able to support with API’s as well.
Yes, our APIs and intermediates are supplied to global markets across multiple regions, supported by strong services and regulatory processes.
Creating original and customer-centric products.













































![2-[(3,5-Dimethylphenoxy)methyl]oxirane](https://punagri.com/wp-content/uploads/2025/04/2-35-Dimethylphenoxymethyloxirane-100x100.png)


















![3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](https://punagri.com/wp-content/uploads/2025/04/3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine-100x100.png)



























